Gene: KCTD7
Official Full Name: potassium channel tetramerization domain containing 7provided by HGNC
Gene Summary: This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16817 | KCTD7 Knockout cell line (HeLa) | Human | KCTD7 | 1:3~1:6 | Negative | Online Inquiry |
KO16818 | KCTD7 Knockout cell line (HCT 116) | Human | KCTD7 | 1:2~1:4 | Negative | Online Inquiry |
KO16819 | KCTD7 Knockout cell line (HEK293) | Human | KCTD7 | 1:3~1:6 | Negative | Online Inquiry |
KO16820 | KCTD7 Knockout cell line (A549) | Human | KCTD7 | 1:3~1:4 | Negative | Online Inquiry |
KCTD7 Gene Knockout Cell Lines represent a specialized biological tool designed to facilitate the study of KCTD7, a member of the potassium channel tetramerization domain-containing family known for its role in neural development and synaptic function. This product features engineered cell lines with stable deletions of the KCTD7 gene, enabling researchers to investigate the gene’s cellular functions, pathways, and associated phenotypes in a controlled environment.
The primary mechanism of action for these knockout cell lines lies in the precise disruption of KCTD7 expression, allowing for the assessment of downstream signaling pathways and interactions that are typically influenced by this gene. Researchers can utilize these cell lines to explore the implications of KCTD7 loss on neuronal activity, differentiation, and susceptibility to neurodevelopmental disorders, thereby clarifying its physiological significance.
In terms of scientific importance, KCTD7 is implicated in various research areas, including neurobiology, genetics, and pharmacology. The knockout cell lines serve as invaluable models for investigating KCTD7-related pathologies, enabling breakthroughs in understanding neurodegenerative diseases and developing targeted therapeutic interventions.
Compared to similar products on the market, KCTD7 Gene Knockout Cell Lines are distinguished by their high specificity, reproducibility, and rigorous validation processes. Our lines are created using state-of-the-art CRISPR/Cas9 technology, ensuring efficient and accurate gene editing that maximizes operational efficiency for researchers while minimizing off-target effects.
For researchers and clinicians, the KCTD7 Gene Knockout Cell Lines are not merely tools but gateways to unlocking complex biological systems. They enhance experimental accuracy and provide researchers with the confidence necessary to explore novel hypotheses. Investing in these cell lines translates to a commitment to advancing scientific knowledge and therapeutic discovery.
Our company possesses profound expertise in gene editing and cell line development, emphasizing research integrity and innovation. We are dedicated to providing high-quality biological products that empower scientific discovery and enable researchers to push the boundaries of their investigations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.